Cargando…
Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
While the guidelines for adjuvant chemotherapy (AC) for colon cancer are relatively standardized, those for early rectal cancer are still lacking. We therefore evaluated the role of AC in clinical stage II rectal cancer treatment after preoperative chemoradiotherapy (CRT). Patients diagnosed with ea...
Autores principales: | Bang, Hyun Jin, Shim, Hyun Jeong, Hwang, Jun Eul, Bae, Woo Kyun, Chung, Ik Joo, Cho, Sang Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chonnam National University Medical School
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900219/ https://www.ncbi.nlm.nih.gov/pubmed/36794240 http://dx.doi.org/10.4068/cmj.2023.59.1.76 |
Ejemplares similares
-
Geriatric functional assessment for decision-making on adjuvant chemotherapy in older colon cancer patients
por: Bang, Hyun Jin, et al.
Publicado: (2022) -
Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021) -
The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
por: Kim, Ka-Rham, et al.
Publicado: (2017) -
The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
por: Shim, Hyun-Jeong, et al.
Publicado: (2016) -
Complete biologic response to taxane based chemotherapy confirmed by [(18)F]FDG PET/CT and surgery in a cancer of unknown primary site
por: Hwang, Jun-Eul, et al.
Publicado: (2012)